Among the current 10 million American chronic abusers of alcohol, 1 to 2% or nearly 200,000 people will develop alcohol-induced heart muscle disease (AIHMD), but the pathogenesis of this disorder remains obscure. Furthermore, although changes have been documented in myocardial intermediary metabolism after ethanol exposure, such as triacylglyceride accumulation and decreased beta-oxidation of fatty acids, lack of demonstration of ethanol metabolism by the heart has impaired elucidation of the pathogenesis of AIHMD. Recent results from our laboratory documented direct metabolism of ethanol by heart homogenates and isolated perfused rabbit hearts. In these studies a specific product of myocardial ethanol metabolism, fatty acid ethyl esters (FAEE), was identified for the first time. We have also identified FAEE in hearts from human subjects who died while inoxicated (n = 3). The studies proposed here are designed to pursue the pathopysiological implications of these observations by quantitating formation of these already identified products and delineating mechanisms of FAFE formation and degradation with respect to subcellular localization, responsible enzymes, substrate dependence, and organ specificity of the metabolic pathways involved. the biological significance of products of ethanol metabolism will be characterized by evaluation of their interactions with triacylglycerol lipase,since preliminary data indicate that they may act as competitive substrates, and by evaluation of their effects on beta-oxidation of fatty acids. In addition, the cellular electrophysiological effects of these metabolic products will be assesed since FAEE may contribute to dysrhythmias commonly associated with AIHMD. Cardiac metabolism of ethanol will be assessed also after administration of ethanol in vivo. Myocardial specimens will be obtained from an available colony of rats chronically depedent on ethanol for determination of FAEE concentrations and activities of enzymes responsible for their biosynthesis and degradation to determine whether induction or suppression occurs. The goal of the proposed studies is characterization of myocardial products of ethanol metabolism and assessment of their possible contributions to abnormalities associated with development of AIHMD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA006989-02
Application #
3110475
Study Section
Biochemistry Study Section (BIO)
Project Start
1985-11-19
Project End
1988-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Smith, C M; Bora, P S; Bora, N S et al. (1995) Genetic and radiation-reduced somatic cell hybrid sublocalization of the human GSTP1 gene. Cytogenet Cell Genet 71:235-9
Bello, A T; Bora, N S; Lange, L G et al. (1994) Cardioprotective effects of alcohol: mediation by human vascular alcohol dehydrogenase. Biochem Biophys Res Commun 203:1858-64
Bora, P S; Bora, N S; Wu, X et al. (1994) Molecular cloning, sequencing, and characterization of smooth muscle myosin alkali light chain from human eye cDNA: homology with myocardial fatty acid ethyl ester synthase-III cDNA. Genomics 19:186-8
Bora, P S; Lange, L G (1993) Molecular mechanism of ethanol metabolism by human brain to fatty acid ethyl esters. Alcohol Clin Exp Res 17:28-30
Isenberg, K E; Bora, P S; Zhou, X et al. (1992) Nonoxidative ethanol metabolism: expression of fatty acid ethyl ester synthase-III in cultured neural cells. Biochem Biophys Res Commun 185:938-43
Bora, P S; Wu, X; Lange, L G (1992) Site-specific mutagenesis of two histidine residues in fatty acid ethyl ester synthase-III. Biochem Biophys Res Commun 184:706-11
Bora, P S; Wu, X; Spilburg, C A et al. (1992) Purification and characterization of fatty acid ethyl ester synthase-II from human myocardium. J Biol Chem 267:13217-21
Bora, P S; Bora, N S; Wu, X L et al. (1991) Molecular cloning, sequencing, and expression of human myocardial fatty acid ethyl ester synthase-III cDNA. J Biol Chem 266:16774-7
Gulick, T; Pieper, S J; Murphy, M A et al. (1991) A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses. Circulation 84:313-21
Kinnunen, P M; Klopf, F H; Bastiani, C A et al. (1990) 12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoic acid: biological recognition by cholesterol esterase and acyl-CoA:cholesterol O-acyltransferase. Biochemistry 29:1648-54

Showing the most recent 10 out of 21 publications